Results 211 to 220 of about 221,219 (252)

Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care

Current Opinion in Cardiology, 2023
Purpose of review Some experts and consensus groups continue to argue that apolipoprotein B (apoB) should not be introduced broadly into clinical care. But, too often, the present approach to clinical care is not succeeding.
Selin, Bilgic, Allan D, Sniderman
openaire   +2 more sources

Non-high-density lipoprotein cholesterol

Current Opinion in Lipidology, 2015
In this review, we summarize the evidence with regard to the rationale of using nonhigh density lipoprotein cholesterol (non-HDL-C) as a cardiovascular disease (CVD) risk factor, in relation to low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apoB).In the 2015 National Lipid Association Annual Summary non-HDL-C is considered a ...
Rutger, Verbeek, G Kees, Hovingh, S Matthijs, Boekholdt   +2 more
openaire   +2 more sources

NON-HIGH DENSITY LIPOPROTEIN CHOLESTEROL AND TREATMENT TARGETS IN VASCULAR SURGERY PATIENTS

Journal of the American College of Cardiology, 2022
Introduction Low-density lipoprotein cholesterol (LDL) is a known contributing factor to atherosclerotic cardiovascular disease (ASCVD) and a primary therapeutic target for medical management of ASCVD. Non-high-density lipoprotein cholesterol (non-HDL) has recently been identified as a secondary therapeutic ...
Drew J Braet, Kian Pourak, Vibav Mouli, Itai Palmon, Dan Dinh, Nicholas H Osborne, Chandu Vemuri, Eric J Brandt   +7 more
openaire   +2 more sources

Non–High-Density Lipoprotein Cholesterol: The Forgotten Therapeutic Target

The American Journal of Cardiology, 2005
The National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) has acknowledged mounting evidence of an independent association between hypertriglyceridemia and coronary artery disease risk by issuing guidelines that identify non-high-density lipoprotein (HDL) cholesterol as a secondary target for therapy in patients with ...
Kevin C, Maki, Ron, Galant, Michael H, Davidson   +2 more
openaire   +2 more sources

Discordance of apolipoprotein B with low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol and coronary atherosclerosis

European Journal of Preventive Cardiology, 2022
Abstract Aims High level of apolipoprotein B (Apo B) is associated with incident subclinical atherosclerosis. The present study evaluated the associations between discordant Apo B with low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and coronary ...
Xin Su, Xueli Cai, Yuesong Pan, Jingping Sun, Jing Jing, Mengxing Wang, Xia Meng, Yongjun Wang, Tiemin Wei, Yan He   +9 more
openaire   +2 more sources

Non-High-Density Lipoprotein Cholesterol in Patients with Metabolic Syndrome

Journal of Investigative Medicine, 2008
Background Metabolic syndrome (MS) represents a cluster of cardiovascular risk factors that includes hypertriglyceridemia. Although low-density lipoprotein (LDL) cholesterol is the critical therapeutic target in patients with coronary artery disease, LDL cannot be calculated in those with excessive ...
Jian, Huang, Roy, Parish, Ishak, Mansi, Herbert, Yu, Estela M, Kennen, Terry, Davis, Donna, Carden   +6 more
openaire   +2 more sources

Utility of non-high-density lipoprotein cholesterol in hemodialyzed patients

Metabolism, 2004
Non-high-density lipoprotein-cholesterol (HDL-C) is proposed as a strong predictor of cardiovascular disease (CVD). Measuring non-HDL-C, as total cholesterol minus HDL-C, is convenient for routine practice because, among other advantages, fasting is not required. There are limited data of non-HDL-C in end-stage renal disease patients.
Laura, Schreier, Ana I, González, Alicia, Elbert, Gabriela, Berg, Regina, Wikinski   +4 more
openaire   +2 more sources

Non-high-density lipoprotein cholesterol and cardiovascular disease

Current Opinion in Lipidology, 2003
Non-HDL cholesterol was designated a secondary target of therapy in the recent Adult Treatment Panel III report. This paper reviews correlates of non-HDL cholesterol levels and summarizes the available data on non-HDL cholesterol as a predictor of cardiovascular events as well as data linking treatment-induced changes in non-HDL cholesterol to ...
openaire   +2 more sources

Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement

Journal of Clinical Lipidology, 2011
There is little understanding of the reliability of laboratory measurements among clinicians. Low-density lipoprotein cholesterol (LDL-C) measurement is the cornerstone of cardiovascular risk assessment and prevention, but it is fraught with error. Therefore, we have reviewed issues related to accuracy and precision for the measurement of LDL-C and the
John H, Contois, G Russell, Warnick, Allan D, Sniderman   +2 more
openaire   +2 more sources